文献速递脊柱关节炎

外周表现在新发脊柱关节炎中是疾病表型和结局的主要决定因素

Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

基于比利时全国前瞻性起始队列Be-Giant,纳入367例新发成人脊柱关节炎(SpA)患者,其中162例(44%)有外周表现。聚类分析识别出中轴优势型(A组,n=248)和外周优势型(B组,n=119)两个表型;纵向分析(n=115)显示两簇各存在持续高疾病活动(「High」)和快速降至低疾病活动(「Low」)两条轨迹。在A组中,外周表现 predispose 至「High」轨迹(OR=2.0,95%CI:1.3,3.1,P=0.001),尽管生物制剂启动更快(HR=2.1,95%CI:1.0,4.4,P=0.04)。

要点

  • 新发SpA中44%(162/367)存在外周表现,聚类分析识别出中轴优势型和外周优势型两个表型。
  • 中轴优势型中伴外周表现者更易进入持续高疾病活动轨迹(OR=2.0,95%CI:1.3,3.1,P=0.001)。
  • 该组生物制剂启动更快(HR=2.1,95%CI:1.0,4.4,P=0.04),但结局仍不利。

核心结论

  • 外周肌肉骨骼表现是新发SpA表型多样性的主要决定因素。
  • 按是否伴外周受累对中轴型SpA分层,识别出尽管更早强化生物制剂治疗但结局仍不利的内表型。
  • 作者认为这些观察结果支持超越现行ASAS/EULAR管理推荐的内表型定制方法。

研究设计与样本

  • 前瞻性观察性全国起始队列Be-Giant,纳入符合ASAS中轴型或外周型SpA分类标准的初诊成人SpA患者,每6个月随访。
  • 2010年11月至2020年3月共入组367例患者,其中162例(44%)有外周表现。
  • 采用K-means聚类分析和潜类别增长分析,在基线识别临床相似患者亚组及两年随访期间的疾病活动模式。

主要发现

  • 基线识别出两个患者簇:A簇中轴优势型(n=248)和B簇外周优势型(n=119)。
  • 纵向分析(n=115)显示每个簇内存在两条疾病活动轨迹:持续高疾病活动(「High」)和快速降至低疾病活动(「Low」)。
  • 在A簇患者中,外周表现 predispose 至「High」轨迹(OR=2.0,95%CI:1.3,3.1,P=0.001)。
  • A簇中伴外周表现者较无外周表现者生物制剂启动更快(HR=2.1,95%CI:1.0,4.4,P=0.04,Cox比例风险模型)。

关键数值与推荐

  • 外周受累定义为关节炎、附着点炎和/或指趾炎。
  • A簇中伴外周表现者进入「High」轨迹的OR=2.0(95%CI:1.3,3.1,P=0.001)。
  • A簇中伴外周表现者生物制剂启动的HR=2.1(95%CI:1.0,4.4,P=0.04)。

临床怎么用

  • 原文结论认为这些观察结果支持超越现行ASAS/EULAR管理推荐的内表型定制方法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To delineate the impact of peripheral musculoskeletal manifestations on stratification of disease phenotype and outcome in new-onset spondyloarthritis (SpA), using a prospective observational nationwide inception cohort, the BelGian Inflammatory Arthritis and spoNdylitis cohorT (Be-Giant). METHODS: Newly diagnosed adult SpA patients, fulfilling the Assessment of SpondyloArthritis International Society (ASAS) criteria for axial or peripheral SpA, were included in Be-Giant and prospectively followed every six months. Peripheral involvement (defined as arthritis, enthesitis and/or dactylitis) was determined in relation to clinically similar patient subsets at baseline and disease activity patterns during two-year follow-up, identified through K-means cluster analysis and latent class growth analysis. RESULTS: From November 2010 to March 2020, 367 patients were enrolled in Be-Giant, of whom 162 (44%) had peripheral manifestations. Two patient clusters [A, axial predominant (n = 248) and B, peripheral predominant (n = 119)] were identified at diagnosis. Longitudinal analysis (n = 115) revealed two trajectories of disease activity in each cluster: one with persistently high disease activity over time ('High'), the other rapidly evolving to low disease activity ('Low'). In cluster A patients, peripheral manifestations predisposed to the 'High' trajectory [odds ratio (OR) = 2.0, 95% CI: 1.3, 3.1, P = 0.001], despite more rapid initiation of biologics compared with patients without peripheral manifestations (hazard ratio (HR) = 2.1, 95% CI: 1.0, 4.4, P = 0.04 - Cox proportional-hazards model). CONCLUSION: Peripheral musculoskeletal manifestations are major determinants of phenotypical diversity in new-onset SpA. Intriguingly, stratification of axial SpA according to concomitant peripheral involvement identified an endotype with an unfavorable outcome despite more prompt therapeutic intensification with biologics. These observations justify an endotype-tailored approach beyond current ASAS/EULAR management recommendations.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. De Craemer AS, Renson T, Deroo L, et al. Peripheral manifestations are major determinants of disease phenotype and outcome in new onset spondyloarthritis. Rheumatology (Oxford). 2022. PMID: 34850859. doi:10.1093/rheumatology/keab887

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。